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Measures in autopsied brains from Alzheimer's Disease (AD) patients reveal a decrease in the activity of α-ketoglutarate dehydrogenase
complex (KGDHC) and an increase in malate dehydrogenase (MDH) activity. The present experiments tested whether both changes could be
caused by the common oxidant H2O2 and to probe the mechanism underlying these changes. Since the response to H2O2 is modified by the level
of the E2k subunit of KGDHC, the interaction of MDH and KGDHC was studied in cells with varying levels of E2k. In cells with only 23% of
normal E2k protein levels, one-hour treatment with H2O2 decreased KGDHC and increased MDH activity as well as the mRNA level for both
cytosolic and mitochondrial MDH. The increase in MDH did not occur in cells with 100% or 46% of normal E2k. Longer treatments with H2O2
inhibited the activity of both enzymes. Glutathione is a major regulator of cellular redox state and can modify enzyme activities. H2O2 converts
reduced glutathione (GSH) to oxidized glutathione (GSSG), which reacts with protein thiols. Treatment of purified KGDHC with GSSG leads to
glutathionylation of all three KGDHC subunits. Thus, cellular glutathione level was manipulated by two means to determine the effect on KGDHC
and MDH activities. Both buthionine sulfoximine (BSO), which inhibits glutathione synthesis without altering redox state, and H2O2 diminished
glutathione to a similar level after 24 h. However, H2O2, but not BSO, reduced KGDHC and MDH activities, and the reduction was greater in the
E2k-23 line. These findings suggest that the E2k may mediate diverse responses of KGDHC and MDH to oxidants. In addition, the differential
response of activities to BSO and H2O2 together with the in vitro interaction of KGDHC with GSSG suggests that glutathionylation is one
possible mechanism underlying oxidative stress-induced inhibition of the TCA cycle enzymes.
© 2008 Published by Elsevier B.V.Keywords: α-ketoglutarate dehydrogenase complex; Alzheimer's disease; Glutathione; Malate dehydrogenase; Reactive oxygen species1. Introduction
Diminished energy metabolism and enhanced oxidative stress
[excess of reactive oxygen species (ROS) to antioxidants] are
consistent features of Alzheimer's disease (AD) [1–5]. Recent
studies on brains of patients that died with AD indicate a selec-
tive modification of the mitochondrial tricarboxylic acid (TCA)
cycle, a major pathway of the oxidative metabolism. The TCA
cycle consists of eight enzymes including the α-ketoglutarate
dehydrogenase complex (KGDHC, EC 1.2.4.2, EC 2.3.1.61, EC
1.6.4.3) and malate dehydrogenase (MDH, EC 1.1.1.37). The⁎ Corresponding author. Tel.: +1 914 597 2291; fax: +1 914 597 2757.
E-mail address: ggibson@med.cornell.edu (G.E. Gibson).
0925-4439/$ - see front matter © 2008 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2007.12.008activity ofKGDHCdeclines inAD [6–12], whileMDHactivity is
elevated [13]. The mechanism of the diverse response of the TCA
cycle enzymes in AD is unknown. Our previous studies suggest
that oxidants can mimic the diverse changes that accompany AD.
For example, hydrogen peroxide (H2O2) mimics the increase in
endoplasmic reticulum calcium stores and the decline in the
activity of KGDHC [14].
KGDHC consists of three subunits [α-ketoglutarate dehydro-
genase (E1k), dihydrolipoyl succinyltransferase (E2k) and dihy-
drolipoyl dehydrogenase (E3)] and is a key and arguably rate-
limiting enzyme in the TCA cycle [10]. Multiple copies of E1k
(12 dimers) and E3 (6 dimers) are arranged along the edges and
faces, respectively, of an octahedral E2k core (24 subunits) to
form a multienzyme complex with a molecular weight of around
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normal and pathologically involved brain areas of patients with
number of neurodegenerative diseases includingAD, Parkinson's
disease (PD), progressive supranuclear palsy and Wernicke–
Korsakoff syndrome [6,10–12,16–21]. In AD patients the re-
duction in the activity of KGDHC is highly correlated to a clinical
dementia rating (CDR) [13]. These results suggest that KGDHC
may play a central role in the pathophysiology of the diseases.
KGDHC is sensitive to a wide range of oxidants whether the
oxidants are added to the purified enzyme or cell system [22–24],
or generated internally in cells or mice [25–27]. H2O2 reduces
KGDHC activity in fibroblasts, intact cardiac mitochondria,
synaptosomes and N2a cells [22,23,28,29]. These results suggest
that oxidative stress is one plausible link between diminished
KGDHC activity and neurodegenerative diseases.
MDH, the final enzyme in the TCA cycle, catalyzes the in-
terconversion of L-malate and oxaloacetate using nicotin-
amide adenine dinucleotide (NAD) as a cofactor (L-malate+
NAD+⇄oxaloacetate+NADH+H+) [30]. Mammalian cells
contain two isozymes of MDH: mitochondrial (mMDH) and
soluble or cytoplasmic (cMDH). The two isozymes consist of
two very similar subunits of about 35,000 Da with similar en-
zymatic activity but appear to be different proteins [31]. Elevated
MDH activity occurs under a number of conditions. For exam-
ple, mice on a caloric restricted diet show increased MDH ac-
tivity compared to mice on a normal diet [32]. Total MDH
activity is also higher in autopsy brains from AD patients com-
pared with brains from normal individuals [13]. However, the
regulation of MDH and its relation to diminished KGDHC ac-
tivity in the disease are unknown.
Glutathione, a tripeptide composed of L-glutamate, L-cysteine
and glycine, is considered to be the most important endogenous
intracellular antioxidant in mammalian cells [33,34]. Reduced
(GSH) and oxidized (GSSG) forms of glutathione are intercon-
vertible by the action of two enzymes, GSH peroxidase and
GSSG reductase [35,36]. Altered glutathione metabolism has
been observed in multiple neurodegenerative diseases [37–39].
For example, GSH declines by 40% in substantia nigra of
PD patients [38]. Whether glutathione level is significantly
reduced in AD remains unclear as many studies are contra-
dictory at various levels. For example, the total brain levels of
GSH appeared to be unaffected in AD [40,41], while GSH
peroxidase (GSH-Px) and GSH reductase (GSH-R) are ele-
vated in different brain regions [42]. Serum GSH-Px activity
is either decreased [43,44] or increased in AD [45]. Another
study [37] compares total and protein-bound thiol levels in the
hippocampus and cerebellum of six Alzheimer's disease (AD)
patients and six age-matched control subjects. Total level of
sulfhydryl (SH) groups is not significantly altered in the hip-
pocampus and cerebellum of AD patients. The level of protein-
bound SH groups decreases in the AD hippocampus compared
with controls. H2O2 induces accumulation of GSSG and GSSG
can form mixed disulfides with cellular protein thiols or in-
traprotein disulfides which leads to altered enzyme functions
[46]. Thus, altered glutathione redox state may mediate changes
in the TCA cycle enzymes under oxidative stress through
glutathionylation.Glutathionylation of KGDHC is one possible mechanism
underlying its inactivation by oxidative stress [47]. In addition to
existence of multiple cysteine residues in the three subunits, a
unique feature of KGDHC is that the E2k subunit has a bound
lipoic acid that is cycled between thiol and disulfide forms
during the catalysis. In non-genetic forms of AD, the immu-
noreactivity of E2k is significantly reduced by 23–41% in the
temporal cortex, while no changes in the E2k protein levels
occur in the parietal cortex and hippocampus [48]. The E2k
protein level is also diminished by 76% in brains of the APP670/
671 (Swedish mutation) family [49]. Our previous study de-
monstrates that the response of cells to H2O2 is modulated by the
E2k and is independent of changes in activity of the complex
[50]. Thus, the E2k subunit of KGDHC may have other novel
functions in modulating oxidative stress-induced changes in the
activities of the TCA cycle enzymes in AD.
Two HEK293 lines expressing E2k antisense RNA, in which
E2k protein contents were reduced to 46% (E2k-46) and 23%
(E2k-23) of a sense control line (E2k-100), were developed in
our previous study [50]. The studies reveal that E2k modifies
ROS production and cell death in response to H2O2. The present
experiments used these cell lines to test whether concentrations
of H2O2 that diminish KGDHC activity increase MDH activity
and if the E2k of KGDHC modulates these changes. The ex-
periments also tested whether GSSG directly interacts with
KGDHC in vitro, and whether manipulation of free glutathione
level by buthionine sulfoximine (BSO, an inhibitor of gluta-
thione synthesis) or H2O2 correlates with changes in KGDHC
and MDH activities.
2. Materials and methods
2.1. Cell cultures and treatments
The E2k-46 and E2k-23 cell lines with half and three-quarters diminished E2k
protein along with the control line (E2k-100) were generated previously [50].
“100”, “46” and “23” represent the protein level of the E2k in the E2k-100, E2k-46
and E2k-23 line, respectively [50]. They were grown in Dulbecco's Modified
Eagle's Medium (DMEM) (high glucose) supplemented with 10% (v/v) fetal
bovine serum (FBS), penicillin (50 U/ml), streptomycin (50 μg/ml) and
hygromycin (100 μg/ml), and incubated at 37 °C in a humidified atmosphere of
5% CO2 in air.
Cells grown in 100-mm cell culture dishes (∼90% confluent) were tryp-
sinized, counted and seeded into six 6-well plates per cell line at a density of
5×104 cells/well, and incubated at 37 °C in a humidified atmosphere of 5% CO2
in air. When near 80–90% confluent, the cells were washed twice with phos-
phate buffered saline (PBS) buffer and treated for 1 or 24 h with the treatments
indicated in the figure legends. At the end of the each treatment, cells including
any floating cells in each well were collected and harvested by centrifugation at
290 g for 5 min at 4 °C. The supernatants were discarded and cell pellets were
washed once with PBS buffer and kept on ice or stored at −80 °C for further use.
2.2. KGDHC activity assay
KGDHC catalyzes the following reaction: α-ketoglutarate+NAD++CoA→
succinyl CoA+CO2+NADH. The assay uses α-ketoglutarate to distinguish
KGDHC produced NADH from NADH generated by other enzymes. Cell pel-
lets were lysed with 250 μl of KGDHC lysis buffer, passed through a 1 ml
syringe with a 27 gauge needle several times and KGDHC activities were
assayed immediately as described previously [10].
Fig. 1. Response of KGDHC and MDH activities to 1 h of H2O2. Values are
means±SEM of specific activity measured from at least three independent
experiments in triplicate. Values with different letters differ significantly from
each other (Pb0.05) as determined by a one-way ANOVA followed by a
Student–Newman–Keul's test.
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MDH catalyzes the following reaction: L-malate+NAD+⇄oxaloacetate+
NADH. The MDH activity was measured by an oxaloacetate-dependent NADH
oxidation assay as described previously [13] with slight modifications. Briefly,
cell pellets were lysed in 250 μl of KGDHC lysis buffer [10] and passed through
a 1 ml syringe with a 27 gauge needle several times. After incubation of the cell
lysate at room temperature for 30 min, 20 μl of blank (lysis buffer), standards
and samples were added to wells of a 96-well plate followed by addition of
140 μl of 100 mM potassium phosphate buffer (pH 7.2) and 20 μl of 20 mM
oxaloacetic acid. The reaction was initiated by adding 20 μl of 10 mMNADH to
the mixture. The plate was read at an excitation wavelength of 340 nm and an
emission wavelength of 460 nm (cutoff 455 nm) at 25 °C for 25 min using a
SPECTRAmax GEMINI XS fluorescence micro-plate reader (Molecular
Devices). The rate of NADH oxidation was corrected with NADH standard
curve and normalized to protein contents as determined by a Bio-Rad protein
assay based on the Bradford dye-binding method (Bio-Rad) using BSA as
standard.
2.4. Real-time PCR
Total RNAwas isolated from cells treated with H2O2 (0.1 and 1 mM) for 1 h
using a RNeasy Mini kit (Qiagen, Valencia, CA) according to the supplier's
instruction. This was followed by first strand cDNA synthesis using the First
Strand cDNA synthesis kit for RT-PCR (AMV) (Roche Applied Science, In-
dianapolis, IN) with oligo-p(dT)15 as primer. Real-time PCR of cytoplasmic
MDH (cMDH) and mitochondrial MDH (mMDH) was performed using an
Applied Biosystems 7500 Real-time PCR system with pre-designed TaqMan®
gene expression assays (Applied Biosystems, Foster City, CA). In brief, each
amplification mixture (50 μl) contained 22.5 μl of cDNA template, 25 μl of
TaqMan® Universal PCRMaster Mix, 2.5 μl of a FAM™ dye labeled TaqMan®
MGB probe and two PCR primers. Thermal cycler conditions were 95 °C for
10 min, and 40 cycles of 95 °C for 15 s and 60 °C for 1 min. All samples were
normalized for beta-2-microglobulin (b2m) expression. A comparative Ct (the
threshold cycle of PCR at which amplified product was first detected) method
was used to compare the mRNA expression in samples treated with H2O2 to that
of the untreated controls.
2.5. GSSG treatment, SDS-PAGE and Western blotting
KGDHC (Sigma) (200 μl) was loaded onto a 2% ABT Agarose column
(Agarose Bead Technologies, Tampa, FL) to remove contaminating bovine
serum albumin. Five of the fractions with the highest KGDHC activity from four
column purifications were pooled and concentrated by Amicon Ultra-15 Centri-
fugal Filer Unit 100 (Millipore, Billerica, MA). Concentrated KGDHC was
incubated with 0, 0.5 or 5 mM oxidized glutathione (GSSG) (Sigma, St. Louis,
MO) in 100mMphosphate buffer (PB) (pH 7.2) at 37 °C for 30min. At the end of
incubation, 5× SDS-sample loading dye [50% glycerol, 250 mM Tris (pH 6.8),
10 mM EDTA, 10% SDS and 0.04% bromophenol blue] was added to the
reaction mixture to achieve 1× final concentration. Electrophoresis was done
with a 4–20%Tris–Glycine gel (Invitrogen; Carlsbad, CA) using 120V for 2.5 h.
Separated proteins were then electrotransferred to a nitrocellulose membrane
(Amersham Biosciences; Piscataway, NJ) using 45 V for 3 h. Blots were blocked
with Tris-buffered saline (TBS)/Ody Blocking buffer (LI-COR Biosciences,
Lincoln, NE) (1:1 in volume) at 4 °C overnight, and incubated with rabbit E1k,
E2k or E3 antibody and anti-glutathione antibody (Virogen, Watertown, MA)
(1:1000 dilution) at room temperature for 3.5 h. After washing thoroughly with
TBS/0.1% Tween-20 at room temperature, the blots were incubated with Od-
yssey Goat anti-rabbit IRDye680 antibody and goat anti-mouse IRDye800CW
antibody at room temperature for 1 h (1:5000; LI-COR Biosciences, Lincoln,
NE). After extensive washing, the membranes were scanned by the Odyssey
Infrared Imaging System (LI-COR Biosciences, Lincoln, NE).
2.6. Total free cellular glutathione measurement
Cell pellets were deproteinized by the addition of 150 μl of 5% ice-cold
metaphosphoric acid (v/v). The samples were vortexed, incubated at 4 °C for25 min and revortexed. Samples were then centrifuged at 10,000 g for 10 min
(4 °C) to separate supernatants from the pellets. The supernatants were carefully
transferred to new 1.5 ml tubes without disturbing the pellets and stored at
−20 °C for glutathione measurement. The pellets were solubilized with 1 N
NaOH and the protein concentrations were measured using a Bio-Rad protein
assay based on the Bradford dye-binding method (Bio-Rad) using bovine serum
albumin (BSA) as standard.
The supernatants containing free thiols were diluted 6-fold with assay buffer
(100 mM NaH2PO4 and 5 mM EDTA, pH 7.5). Total free glutathione was
determined using a microplate method [51] based on the DTNB [5,5′-dithiobis-
(2-nitrobenzoic acid)]/enzymatic re-cycling procedure [52,53]. In brief, 50 μl of
GSH standard or diluted sample extract was added to the wells of a 96-well plate
followed by addition of 50 μl each of 1.26mMDTNB and 2.5 u/ml of glutathione
reductase (Sigma). After incubation at room temperature for 15 min, the reaction
was started by the addition of 50 μl of 0.6 mg/ml of NADPH to each well. After
addition of NADPH, the plate was immediately read in a SPECTRAmax mic-
roplate reader (Molecular Devices). The rate of change in absorbance at 410 nm
was monitored for 3 min at 16-s intervals. All standard and samples were run in
duplicate in adjacent wells. Values were calculated with a GSH standard curve
and normalized with protein contents measured by a Bio-Rad protein assay.
3. Results
3.1. Response of KGDHC and MDH activities to 1 h of H2O2
Whether H2O2 induces diverse changes of the KGDHC and
MDH activities and whether E2k modulates these changes were
tested in all three lines. H2O2 diminished the KGDHC activity
Fig. 2. Response of mRNA level of cMDH and mMDH to 1 h of H2O2. Quantitative real-time PCR was employed to measure the mRNA levels of cytoplasmic MDH
(cMDH) and mitochondrial MDH (mMDH) in the all three lines. Transcript quantitation was measured relative to β-2-microglobulin amplification from the same
sample in parallel. Values in panels A and B are the mean±SEM of fold changes above untreated controls from at least two independent experiments in triplicate.
Different letters or numbers in each panel denote values differ significantly from each other (Pb0.05) as determined with a one-way ANOVA followed by a Student–
Newman–Keul's test.
Fig. 3. Glutathionylation of KGDHC by GSSG. Purified KGDHC was incubated with varying concentrations of GSSG followed by SDS-PAGE and Western blotting
as described in the Materials and Methods. The blots were probed with antibodies to E1k (A), E2k (B) or E3 (C) (red) and to glutathione (green), respectively. The
overlap is represented by yellow.
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16% in the E2k-23 line under normal conditions (Fig. 1B).
Interestingly, 1 h of H2O2 increased MDH activity by 15% but
only in the E2k-23 line (Fig. 1B).
3.2. One hour of H2O2 elevated mRNA level of MDH
The MDH activity measures include both cytosolic and mi-
tochondrial MDH activities. Although activity measures cannot
distinguish between mitochondrial and cytosolic MDH, the two
forms can be readily distinguished at the message level. Relative
quantitative Real-time PCR was used to examine the changes in
the levels of mRNA of cytosolic MDH (cMDH) and mitochon-
drial MDH (mMDH). H2O2 (1 h) increased mRNA level of
cMDH by 16% (0.1 mMH2O2) and 20% (1 mMH2O2) but only
in the E2k-23 line (Fig. 2A). Similarly, the mRNA level of
mMDHwas also elevated by 25% in response to 1 h of H2O2 but
only in the E2k-23 line (Fig. 2B).
3.3. Glutathionylation of KGDHC by GSSG
Glutathionylation of KGDHC is postulated from a previous
study [22]. Thus, whether purified KGDHC interacts with
GSSG was tested by Western blotting. Western blot of E1k
(red)/glutathione (green) showed that treatment of KGDHC
with increased concentration of GSSG induced glutathionyla-
tion of E1k (Fig. 3A). Western blot of E2k (red)/glutathione
(green) showed that the immunoreactivity of glutathione in-
creased with the increased concentration of GSSG (Fig. 3B).
GSSG decreased the immunoreactivity of E3 and increased and
shifted the glutathionylated E3 in a dose dependent manner
(Fig. 3C).
3.4. Response of total free cellular glutathione levels to 1 h of
BSO, H2O2 or H2O2/BSO
Cellular free glutathione level was manipulated by two
means. BSO diminished glutathione by blocking its synthesis.Fig. 4. Total free cellular glutathione levels in response to 1 h of BSO, H2O2 or H2O2
E2k-23 lines treated with BSO, H2O2 or H2O2/BSO for 1 h. Values represent the mean
separate experiments in duplicate. Statistical significance was determined using a on
letters are not significantly different from each other (PN0.05).H2O2 converts GSH to GSSG which binds to cellular proteins.
One hour of BSO, H2O2 or H2O2/BSO did not alter the total free
cellular glutathione levels (GSH and GSSG) in any of the three
lines (Fig. 4). Furthermore, the reduction of E2k had no effect
on the total free cellular glutathione levels (Fig. 4).
3.5. Response of KGDHC and MDH activities to 1 h of BSO,
H2O2 or H2O2/BSO
The effect of BSO, H2O2 or H2O2/BSO on the KGDHC and
MDH activities was tested. BSO did not alter either KGDHC or
MDH activity in any line at any concentrations (Fig. 5). Al-
though no reduction in the total free cellular glutathione oc-
curred at one-hour treatment, H2O2 diminished the KGDHC
activity by 24% in all lines (Figs. 1A and 5A). Moreover, 1 h
of H2O2 increased MDH activity by 15% only in the E2k-23
line (Figs. 1B and 5B). Addition of BSO did not enhance the
changes in the KGDHC or MDH activity induced by H2O2
(Fig. 5).
3.6. Response of total free cellular glutathione levels to 24 h of
BSO, H2O2 or H2O2/BSO
The total free cellular glutathione levels were measured
in the three lines — E2k-100, E2k-46 and E2k-23 treated
with BSO, H2O2 or H2O2/BSO for 24 h. Twenty-four-hour
treatment depleted the total free cellular glutathione level
by 30% to 48% in all three lines (Fig. 6). The reductions in
the total free cellular glutathione levels did not differ sta-
tistically among the three lines. Thus, the reduction in E2k did
not alter BSO or H2O2-induced changes in the total free cel-
lular glutathione.
3.7. Response of KGDHC and MDH activity to 24 h of BSO,
H2O2 or H2O2/BSO
Although total free cellular glutathione declined significantly
after 24 h of exposure to 1 or 10 mM BSO, the activity of neither/BSO. Total free cellular glutathione was measured in the E2k-100, E2k-46 and
±SEM of the total free cellular glutathione (nmol/mg protein) from at least three
e-way ANOVA followed by a Student–Newman–Keul's test. Values with same
Fig. 5. Response of KGDHC and MDH activities to 1 h of BSO, H2O2 or H2O2/BSO. Values are the mean±SEM of KGDHC (A) or MDH activity (B) (mU/mg
protein) from at least three independent experiments in triplicate. Values with different letters are statistically different from each other (Pb0.05) by a one-way
ANOVA followed by a Student–Newman–Keul's test.
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BSO. Twenty-four hours of H2O2 reduced the KGDHC activity
greater in the E2k-46 (−60%) and E2k-23 (−64%) lines than in
the E2k-100 control line (−45%) (Fig. 7A). Addition of BSO didFig. 6. Total free cellular glutathione levels in response to 24 h of BSO, H2O2 or H2O
E2k-23 lines treated with BSO, H2O2 or H2O2/BSO for 24 h. Values represent the m
three separate experiments in duplicate. Statistical significance was determined using
different letters are significantly different from each other (Pb0.05).not enhance the changes in the KGDHC activity induced byH2O2
(Fig. 7A).
Similarly, 24 h of H2O2 reduced the MDH activity greater in
the E2k-23 line (−73%) than in the E2k-100 (−56%) or the E2k-2/BSO. Total free cellular glutathione was measured in the E2k-100, E2k-46 and
ean±SEM of the total free cellular glutathione (nmol/mg protein) from at least
a one-way ANOVA followed by a Student–Newman–Keul's test. Values with
Fig. 7. The responses of KGDHC and MDH activities of the E2k-100, E2k-46 and E2k-23 lines to 24 h of BSO, H2O2 or H2O2/BSO. Values are the mean±SEM of
KGDHC (A) or MDH activity (B) (mU/mg protein) from at least three independent experiments in triplicate. Values with different letters in each panel are significantly
different from each other (Pb0.05) as determined with a one-way ANOVA followed by a Student–Newman–Keul's test.
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MDH activity induced by H2O2 (Fig. 7B).
4. Discussion
Diverse changes in the KGDHC and MDH activities occur in
AD brain [13]. The underlying mechanism of these changes in
AD is unknown. Our data shows that a short exposure of cells to
H2O2 diminished KGDHC activity and increased MDH activity.
While the decrease in KGDHC was independent of E2k, the
increased MDH occurred only in the E2k-23 line in which the
E2k is reduced by more than 75%. Thus, one-hour exposure of
cells with one common oxidant, H2O2 (1 mM), can mimic the
diminishedKGDHC and increasedMDH that occur in AD brain.
In AD brains, both changes in the KGDHC (−57%) and MDH
(+54%) activities are highly correlated with clinical dementia
rating (CDR) score [13], suggesting that the diverse change in
the KGDHC and MDH activities occurs after a chronic pro-
gression of the disease. Thus, it is likely that treatments of cells
with lower dosages of oxidants over a longer period of time may
better mimic AD chronic situation. Further, the effectiveness ofH2O2 on MDH is modified by the levels of E2k protein. H2O2
also exaggerates the endoplasmic reticulum calcium content,
another characteristic of cells from AD patient [14]. Thus, the
data supports the possibility that multiple changes in ADmay be
induced by specific oxidants.
The H2O2-induced increase in MDH is at least partly due to
alterations in transcription. Increased MDH activity by H2O2 (1 h)
in the E2k-23 line is associated with the elevated mRNA levels of
both cytosolic and mitochondrial MDH. H2O2 increases DCF-
detectable reactive oxygen species (ROS) generation more in the
E2k-23 line than in either the E2k-100 or E2k-46 line [50]. Ox-
idative stress up-regulates redox-sensitive transcription factors
such as activator protein 1 (AP-1) [54]. The potential binding site of
AP-1 is predicted in theMDH promoter region. Thus, it is possible
that the greater increase in ROS in the E2k-23 line may act on
transcription of MDH which may lead to the increase in the MDH
activity. Further studies on transcriptional regulation of MDH are
necessary to explore the mechanism of elevated MDH activity in
response to diminished E2k at early stages of oxidative stress.
Glutathione, a major free radical scavenger, is diminished in
a number of neurodegenerative diseases [55–57]. Depletion of
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complex I, II, III and IV activities in neuronal cells [58], and is
hypothesized to be an initial factor in oxidative stress-mediated
neurodegeneration [59]. The oxidative stress that is associated
with neurodegenerative diseases including AD may initiate an
interaction of glutathione withmetabolically important mitochon-
drial enzymes. For example, mitochondrial NADP+-dependent
isocitrate dehydrogenase (IDPm) activity is inactivated through
glutathionylation [60]. The activity of this enzyme is also dimi-
nished in brains from AD patients [13]. The present study on the
interaction of purified KGDHC with GSSG demonstrated that
glutathionylation can occur in all three subunits of KGDHC. This
suggests that the stimulation of GSSG formation by oxidative
stress may modulate KGDHC and modify its normal function.
To test the possible regulation of KGDHC by glutathionyla-
tion in cells, the level of free glutathione was manipulated by
treating cells with either BSO or H2O2 and the consequences on
KGDHC and MDH activities were tested. Total free cellular
glutathione was not diminished by one-hour treatment with
either BSO or H2O2. Nevertheless, the possible interaction of
KGDHC with glutathione following H2O2 cannot be excluded.
Isolated KGDHC is inhibited only by high concentrations of
H2O2 (10 mM) [22]. Lower concentrations of H2O2 do not
affect the isolated enzyme or detergent-solubilized mitochon-
dria, but do inhibit KGDHC in intact mitochondria [47] and in
mammalian cells [23]. These data suggest that inactivation of
KGDHC activity is not due to the direct interaction of peroxide
with the enzyme, but is through redox-sensitive mechanism(s).
Redox-regulated glutathionylation or deglutathionylation is one
possible mechanism to account for the inactivation of KGDHC
by H2O2 [41]. H2O2, but not BSO, diminished KGDHC activity.
H2O2 causes accumulation of oxidized glutathione (GSSG) that
can further form mixed disulfide with cellular protein thiols or
intraprotein disulfides [61–64]. Formation of an intraprotein
disulfide is more common when there are adjacent protein thiols
[65,66]. The unique feature of E2k is its bound lipoic acid with
adjacent sulfhydryl groups that is cycled between thiol andFig. 8. Possible interaction of E2k of KGDHC with glutathione. The KGDH comple
moiety and reoxidation of the dihydrolipoyl moiety, and generates succinyl CoA an
subunits (E1k and E3) during catalysis. The thiol and disulfide of lipoyl moiety cy
intermediates of E2k subunit during catalysis. Glutathionylation of E2k is only tra
(reaction 1). In addition, another E2k intermediate [E2k•Lip(SCoR)(SH)] can react w
with [E2k•Lip(SCoR)(SH)] to form a disulfide product [E2k•Lip(SCoR)(S−)]2 (readisulfide bond during catalysis. Thus, it is likely that initial
glutathionylation of KGDHC occurs at the E2k subunit and
is only transient as its adjacent thiol displaces the GS− to
form an intraprotein disulfide (reaction 1, Fig. 8). In addition,
another E2k intermediate [E2k•Lip(SCoR)(SH)] can react with
GSSG and form E2k•Lip(SCoR)(S-SG) (reaction 2, Fig. 8)
which can further react with [E2k•Lip(SCoR)(SH)] (reaction 3,
Fig. 8). Therefore, at early stages of oxidative stress, interaction
of GSSG with the E2k of KGDHC would be expected to limit
NADH production and reduce KGDHC activity without alte-
ration of glutathione level.
Although the 24-h treatment with BSO or H2O2 reduced the
total free cellular glutathione level similarly in all lines, H2O2, but
not BSO, diminished both KGDHC and MDH activities sig-
nificantly. In addition, H2O2 reduced both KGDHC and MDH
activities most dramatically in the E2k-23 line compared to the
other two lines. It is known that the GSH/GSSG ratio can be
buffered by reaction ofGSSGwith cellular proteins to liberate one
(reaction I) or two GSH (reaction II).
reaction I : PrðSHÞ þ GSSG→PrSSG þ GSH
reaction II : PrðSHÞ2 þ GSSG→PrðSHÞ•ðSSGÞ
þ GSH→PrðSÞ2 þ 2GSH
The E1k, E2k or E3 subunits of KGDHC contain 21, 6 or 10
cysteine residues, respectively. Similar reduction of the total free
cellular glutathione in all lines induced by 24 h of H2O2 could be
a result of glutathionylation of proteins including the three sub-
units of KGDHC. This reaction with E2k would be in addition
to its transient interaction with the E2k of KGDHC. The level
of E2k would then become a limiting factor upon its forma-
tion of intraprotein disulfide mediated by GSSG. Therefore,
greater reduction of the KGDHC activity in the E2k diminished
cells may occur as observed in the E2k-46 and E2k-23 lines.
Moreover, immunoblotting studies on the interaction of purified
KGDHC with GSSG provided another piece of evidence that
glutathionylation can occur in all three subunits of the complex.x catalyzes decarboxylation of α-ketoglutarate, reductive acylation of the lipoyl
d NADH. E2k contains a lipoyl moiety which is swung between the other two
cles during the catalysis. E·Lip(SH)(SH), E·Lip(SCOR)(SH) and E·Lip(S)2 are
nsient as its adjacent thiol displaces the GS− to form an intraprotein disulfide
ith GSSG and form E2k•Lip(SCoR)(S-SG) (reaction 2) which can further react
ction 3).
237Q. Shi et al. / Biochimica et Biophysica Acta 1782 (2008) 229–238Taken together, our findings indicate that glutathione interacts
with KGDHC under H2O2-induced oxidative stress and this may
account for the decline in activity. Furthermore, other mechan-
isms are also likely to contribute to the inhibition. For example,
under pathological conditions in which cytosolic Ca2+ is greatly
elevated,mitochondrial Ca2+ may reach levels that will inactivate
KGDHC [14,67].
Oxidative stress-induced glutathionylation of MDH may
contribute to the diminished activity in cells treated with
H2O2 (24 h). MDH has been shown to be glutathionylated
during oxidative stress [68], and it is inactivated by GSSG
(our unpublished data). Inhibition of KGDHC by H2O2 limits
the amount of reducing equivalents (NADH) [69]. NADPH is
an essential reducing equivalent for both regeneration of
GSH by glutathione reductase and NADPH-dependent Trx
system which are two important antioxidant defense systems.
NADPH can be generated through NADP linked malic
enzyme, NADP linked isocitrate dehydrogenase or nicotina-
mide nucleotide transhydrogenase. The latter converts
NADH to NADPH when an increased demand is imposed
by H2O2 [69,70]. Thus, less amount of NADH available in
the E2k-23 line induced by H2O2 would further exaggerate
oxidative stress and give rise to more profound loss of the
MDH activity (−73%).
In summary, at one-hour treatment, concentrations of H2O2
that diminished KGDHC activity increased MDH activity. The
results mimic the changes found in AD. The response of KGDHC
and MDH activities to H2O2 was altered by the E2k levels. These
findings suggest that the E2k component of KGDHC may
mediate diverse responses of KGDHC and other TCA cycle en-
zymes to oxidants. In addition, the differential response of acti-
vities to BSO and H2O2 together with the in vitro interaction of
KGDHC with GSSG suggests that glutathionylation is one pos-
sible mechanism underlying inhibition of the TCA cycle enzymes
under oxidative stress.
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